CompletedNot Applicable

Talocrural Joint Manipulation in Stroke

Turkey (Türkiye)64 participantsStarted 2024-08-02

Plain-language summary

The primary aim of the study is to investigate the effect of talocrural joint manipulation on the static balance of patients with stroke. The secondary aim of this study is to investigate the effect of talocrural joint manipulation on the dorsiflexion range of motion of patients with stroke.

Who can participate

Age range

45 Years – 75 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 1\. Two months or longer elapsed since the stroke, * 2\. A Mini-Mental State Examination score of 24 or higher, * 3\. The ability to stand independently for 20 seconds or more, * 4\. The ability to walk independently for 10 meters with the use of walking aids or orthoses if necessary, * 5\. Being between 45 and 75 years of age, * 6\. Having a Brunnstrom stage of 4 or above Exclusion Criteria: * 1\. The presence of severe osteoarthritis in the lower extremity, * 2\. The presence of cancer or diabetic neuropathy, * 3\. The presence of vestibular disorder, * 4\. The presence of lower extremity ulceration or amputation, * 5\. History of vertigo, * 6\. Alcohol consumption within the last 24 hours, * 7\. Hemodynamic instability, * 8\. Diagnosis of posterior circulation stroke involving the basilar artery and cerebellum, * 9\. The presence of other neurological disorders (such as multiple sclerosis, Parkinson's disease), * 10\. Having experienced an acute lower extremity injury in the last six weeks, * 11\. History of lower extremity surgery

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Overall Stability Index Measurement

Timeframe: Change from baseline overall stability immediately after intervention

Trial details

NCT IDNCT06523010

SponsorBitlis Eren University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-11-27

Results submitted2024-12-05

View on ClinicalTrials.gov More Stroke trials

Who can participate

Age range

45 Years – 75 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.